HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Congenital prothrombin deficiency: an update.

Abstract
Prothrombin (factor II [FII]) deficiency is a rare inherited coagulation disorder, having a prevalence of approximately 1 in 2,000,000. Two phenotypes can be distinguished: (1) true hypoprothrombinemia (type I deficiency), characterized by concomitantly low levels of the zymogen antigen; and (2) dysprothrombinemia (type II deficiency), characterized by the normal or near-normal synthesis of a dysfunctional protein. In the latter case, recent studies showed that particular mutations in the catalytic domain of active thrombin can even impair the enzyme interaction with antithrombin, favoring thromboembolic diseases. In some cases, hypoprothrombinemia associated with dysprothrombinemia was also described in compound heterozygous defects. Prothrombin is essential for the development of mammalian organisms. No living patient with undetectable plasma prothrombin has been reported to date. Prothrombin is encoded by a ≈21 kb gene located on chromosome 11 and containing 14 exons. Thirty-nine different mutations have been identified and characterized in prothrombin deficiency. Many of these are present in the catalytic site, whereas some involve regulatory domains, such as the anion-binding exosite I, the Na+-binding loop, and the light A-chain. Most hypoprothrombinemia-associated mutations are missense, but nonsense mutations leading to stop codons and one single nucleotide deletion have also been identified. Finally, recent developments in the therapy of congenital prothrombin deficiency are presented and discussed.
AuthorsStefano Lancellotti, Maria Basso, Raimondo De Cristofaro
JournalSeminars in thrombosis and hemostasis (Semin Thromb Hemost) Vol. 39 Issue 6 Pg. 596-606 (Sep 2013) ISSN: 1098-9064 [Electronic] United States
PMID23852823 (Publication Type: Journal Article, Review)
CopyrightThieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Chemical References
  • Prothrombin
  • Thrombin
Topics
  • Blood Coagulation Disorders, Inherited (blood, genetics, therapy)
  • Catalytic Domain (genetics)
  • Genotype
  • Humans
  • Models, Molecular
  • Mutation
  • Prothrombin (chemistry, genetics, metabolism)
  • Thrombin (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: